Monoclonal antibody 31.1
Alternative Names: 31.1 MAbLatest Information Update: 23 Dec 2002
Price :
$50 *
At a glance
- Originator International BioImmune Systems
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Colorectal cancer
Most Recent Events
- 23 Dec 2002 Discontinued - Preclinical for Colorectal cancer in USA (unspecified route)
- 14 Jul 1997 New profile
- 16 May 1997 Preclinical development for Colorectal cancer in USA (Unknown route)